Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ALZN002 / Alzamend Neuro
ALZN002-01, NCT05834296: Study in Subjects With Mild-to-Moderate Alzheimer's Dementia	Active, not recruiting	1/2	30	US	ALZN002 (autologous DCs pulsed with E22W mutant peptide)., Placebo	Alzamend Neuro, Inc., bioRASI, LLC	Alzheimer Disease	03/28	03/28